Mesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Multivariate Analysis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Multiple Sclerosis < Multivariate Analysis < Muscle Fatigue  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000345 (2019) Natalia Cabrera [France] ; Jean-Christophe Lega [France] ; Behrouz Kassai [France] ; Carine Wouters [Belgique] ; Anuela Kondi [France] ; Elvira Cannizzaro [Suisse] ; Andreas Woerner [Suisse] ; Aurelie Chausset [France] ; Samuel Roethlisberger [Suisse] ; Cyril Jeanneret [Suisse] ; Florence Aeschlimann [Suisse] ; Salma Malik [France] ; Agnès Duquesne [France] ; Daniela Kaiser [Suisse] ; Laetitia Higel [France] ; Anne Maes [Belgique] ; Gerald Berthet [Suisse] ; Veronique Hentgen [France] ; Isabelle Kone-Paut [France] ; Alexandre Belot [France] ; Michael Hofer [Suisse]Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database.
000701 (2018) Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France]Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.
000745 (2018) Thomas Frisell [Suède] ; Eva Baecklund [Suède] ; Karin Bengtsson [Suède] ; Daniela Di Giuseppe [Suède] ; Helena Forsblad-D'Elia [Suède] ; Johan Askling [Suède]Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.
000872 (2018) Ciriana Orabona [Italie] ; Giada Mondanelli [Italie] ; Maria T. Pallotta [Italie] ; Agostinho Carvalho [Portugal] ; Elisa Albini [Italie] ; Francesca Fallarino [Italie] ; Carmine Vacca [Italie] ; Claudia Volpi [Italie] ; Maria L. Belladonna [Italie] ; Maria G. Berioli [Italie] ; Giulia Ceccarini [Italie] ; Susanna Mr Esposito [Italie] ; Raffaella Scattoni [Italie] ; Alberto Verrotti [Italie] ; Alessandra Ferretti [Italie] ; Giovanni De Giorgi [Italie] ; Sonia Toni [Italie] ; Marco Cappa [Italie] ; Maria C. Matteoli [Italie] ; Roberta Bianchi [Italie] ; Davide Matino [Italie] ; Alberta Iacono [Italie] ; Matteo Puccetti [Italie] ; Cristina Cunha [Portugal] ; Silvio Bicciato [Italie] ; Cinzia Antognelli [Italie] ; Vincenzo N. Talesa [Italie] ; Lucienne Chatenoud [France] ; Dietmar Fuchs [Autriche] ; Luc Pilotte ; Benoît Van Den Eynde ; Manuel C. Lemos [Portugal] ; Luigina Romani [Italie] ; Paolo Puccetti [Italie] ; Ursula Grohmann [Italie]Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.
000C85 (2016) Naonobu Sugiyama [Japon] ; Yutaka Kawahito [Japon] ; Takao Fujii [Japon] ; Tatsuya Atsumi [Japon] ; Tatsunori Murata [Japon] ; Yosuke Morishima [Japon] ; Yuri Fukuma [Japon]Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-world Analysis of Nationwide Japanese Claims Data.
000E21 (2016) Tadashi Okano [Japon] ; Kentaro Inui [Japon] ; Masahiro Tada [Japon] ; Yuko Sugioka [Japon] ; Kenji Mamoto [Japon] ; Shigeyuki Wakitani [Japon] ; Tatsuya Koike [Japon] ; Hiroaki Nakamura [Japon]Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study.
000E45 (2016) Mar Maldonado-Montoro [Espagne] ; Marisa Ca Adas-Garre [Espagne] ; Alfonso González-Utrilla [Espagne] ; José Cristian Plaza-Plaza [Chili] ; Miguel Ngel Calleja-Hernández [Espagne]Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.
000F32 (2016) Mitsuhiro Akiyama [Japon] ; Yuko Kaneko [Japon] ; Kunihiro Yamaoka [Japon] ; Harumi Kondo [Japon] ; Tsutomu Takeuchi [Japon]Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.
001082 (2015) Konstantinos Makrilakis [Grèce] ; Kalliopi Fragiadaki ; Jacqueline Smith ; Petros P. Sfikakis ; George D. KitasInterrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade.
001167 (2015) Vasco C. Romão [Portugal] ; Maria José Santos [Portugal] ; Joaquim Polido-Pereira [Portugal] ; Cátia Duarte [Portugal] ; Patrícia Nero [Portugal] ; Cláudia Miguel [Portugal] ; José Ant Nio Costa [Portugal] ; Miguel Bernardes [Portugal] ; Fernando M. Pimentel-Santos [Portugal] ; Filipe Barcelos [Portugal] ; Lúcia Costa [Portugal] ; José Ant Nio Melo Gomes [Portugal] ; José Alberto Pereira Da Silva [Portugal] ; Jaime Cunha Branco [Portugal] ; José Canas Da Silva [Portugal] ; José Ant Nio Pereira Da Silva [Portugal] ; João Eurico Fonseca [Portugal] ; Helena Canhão [Portugal]Comparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.pt.
001305 (2014) Taro Iwamoto ; Kei Ikeda ; Junichi Hosokawa ; Mieko Yamagata ; Shigeru Tanaka ; Ayako Norimoto ; Yoshie Sanayama ; Daiki Nakagomi ; Kentaro Takahashi ; Koichi Hirose ; Takao Sugiyama ; Makoto Sueishi ; Hiroshi NakajimaPrediction of relapse after discontinuation of biologic agents by ultrasonographic assessment in patients with rheumatoid arthritis in clinical remission: high predictive values of total gray-scale and power Doppler scores that represent residual synovial inflammation before discontinuation.
001314 (2014) Jose Ramon Maneiro [Espagne] ; Eva Perez-Pampin ; Eva Salgado ; Loreto Carmona ; Juan J. Gomez-ReinoObservational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience.
001398 (2014) Nobunori Takahashi [Japon] ; Toshihisa Kojima ; Atsushi Kaneko ; Daihei Kida ; Yuji Hirano ; Takayoshi Fujibayashi ; Yuichiro Yabe ; Hideki Takagi ; Takeshi Oguchi ; Hiroyuki Miyake ; Takefumi Kato ; Naoki Fukaya ; Hisato Ishikawa ; Masatoshi Hayashi ; Seiji Tsuboi ; Yasuhide Kanayama ; Daizo Kato ; Koji Funahashi ; Hiroyuki Matsubara ; Yosuke Hattori ; Masahiro Hanabayashi ; Shinya Hirabara ; Kenya Terabe ; Yutaka Yoshioka ; Naoki IshiguroClinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity.
001C83 (????) Leticia Leon [Espagne] ; Alejandro Gomez [Espagne] ; Cristina Vadillo [Espagne] ; Esperanza Pato [Espagne] ; Luis Rodriguez-Rodriguez [Espagne] ; Juan Angel Jover [Espagne] ; Lydia Abasolo [Espagne]Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice.
001D38 (????) Laure Gossec [France] ; Ghislaine Steinberg [France] ; Stephanie Rouanet [France] ; Bernard Combe [France]Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The French multicentre prospective PEPS Study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Multivariate Analysis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Multivariate Analysis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Multivariate Analysis
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021